The pandemic has had a major impact on the healthcare and pharmaceutical sector and has caused a lot of socio-economic burden. There are a lot of short term and long term impacts which need identification, such as:
– The short term impacts of Covid-19 pandemic include a change in the demand, revisions in the regulations, changes in research and development, and the introduction of tele-medicine and tele-communication.
– The long term impacts of Covid-19 include a slower growth of the industry, approval delays, trend changes in consumption of health-market products and a concern with moving towards self-sufficiency in pharma-production supply chain. These problems relate to both local and global levels.
Hence, the pandemic has posed a considerable crises in the health markets and the pharmaceutical sector. However, the identification of these effects can guide the policy makers to achieve a more evidence-informed planning for overcoming various challenges.
Unimarck Pharma is one of the most reputed pharma companies in India and strives to increase and enhance the access to high quality healthcare through the development of producing and marketing affordable brands in India. Pharmaceutical companies exist to ensure the well-being of others, and Unimarck Pharma does exactly that with the joint effort of its team members.